• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, November 20, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Cancer

Exercise Mapping Clarifies Supportive Care for Chemotherapy-Induced Peripheral Neuropathy

by
November 20, 2026
in Cancer, Health
Reading Time: 2 mins read
0
Exercise Mapping Clarifies Supportive Care for Chemotherapy-Induced Peripheral Neuropathy

Exercise Mapping Clarifies Supportive Care for Chemotherapy-Induced Peripheral Neuropathy

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A scoping review and evidence mapping analysis evaluated how exercise interventions alleviate chemotherapy-induced peripheral neuropathy across different neurotoxic chemotherapy protocols. Researchers reviewed literature published between 2018 and 2025 to characterize intervention parameters and reported clinical outcomes in cancer patients undergoing treatment.

The synthesis identified 31 qualifying studies, of which 77.4 percent were randomized controlled trials. Across the evaluated study populations, 77.4 percent received taxane-based chemotherapy regimens, while 61.3 percent were treated with platinum-based agents. Notably, only 12.5 percent of the analyzed investigations focused specifically on post-treatment cancer survivors.

Multimodal exercise regimens emerged as the predominant intervention design, representing 58.1 percent of the examined programs. These structured physical activities were delivered across clinical settings using home-based, directly supervised, and hybrid formats, though participant adherence was tracked primarily through subjective self-report tools.

The primary outcome measures assessed across the evidence base centered on patient-reported neuropathic symptom severity and overall health-related quality of life. The reviewers noted substantial heterogeneity across individual study designs, including varied exercise modalities, intervention lengths, and clinical assessment instruments.

Methodological quality assessments conducted with the Mixed Methods Appraisal Tool demonstrated higher reporting quality for established interventions, such as aerobic and resistance training, which scored between 4 and 5. Less conventional approaches, including neurodynamic movements and therapeutic dance, exhibited lower reporting standards.

The review concludes that physical exercise represents a feasible supportive strategy for mitigating neuropathy burden. However, scarce agent-specific reporting and non-standardized exercise protocols continue to prevent definitive conclusions regarding optimal interventions for specific neurotoxic drugs.

To identify relevant publications, the investigators conducted comprehensive searches across PubMed, Web of Science, and Scopus databases in strict adherence to the PRISMA-ScR guidelines. Methodological quality across the reviewed corpus was appraised using the Mixed Methods Appraisal Tool, while evidence patterns were visually mapped using bubble plots categorizing specific neurotoxic agents alongside distinct exercise types.

The synthesized findings highlighted that exercise functions as a feasible and potentially effective supportive care approach to diminish the symptom burden of chemotherapy-induced peripheral neuropathy. Nevertheless, high-quality investigations providing transparent distribution data for neurotoxic agents and utilizing standardized intervention protocols remain sparse across the medical literature. This reporting deficit impedes researchers from drawing direct comparisons across individual chemotherapy agents, ultimately precluding definitive drug-specific recommendations.

Consequently, the authors emphasized that therapeutic physical interventions must be tailored according to specific neurotoxic chemotherapy regimens as well as patients’ heterogeneous clinical presentations. They recommended integrating these personalized regimens into multidisciplinary supportive cancer care pathways alongside objective monitoring approaches rather than relying entirely on unverified patient self-reporting tools.

Subject of Research: Exercise interventions for chemotherapy-induced peripheral neuropathy management

Article Title: Exercise interventions in the management of peripheral neuropathy according to neurotoxic chemotherapy agents: A scoping review and evidence mapping

Article References: Eroğlu, İ., & Kutlutürkan, S. (2026). Exercise interventions in the management of peripheral neuropathy according to neurotoxic chemotherapy agents: A scoping review and evidence mapping. Supportive Care in Cancer, 34(12), Article 1259. https://doi.org/10.1007/s00520-026-11496-y

Image Credits: AI Generated

DOI: 10.1007/s00520-026-11496-y

Keywords: chemotherapy-induced peripheral neuropathy, exercise interventions, scoping review, evidence mapping, taxane chemotherapy, platinum chemotherapy, multimodal exercise, supportive care in cancer, aerobic exercise, resistance training, randomized controlled trials, neuropathic symptoms, quality of life, mixed methods appraisal tool, neurotoxic agents, cancer rehabilitation

News Source: Nathaniel Bowman. (November 20, 2026). Exercise Mapping Clarifies Supportive Care for Chemotherapy-Induced Peripheral Neuropathy. Scienmag.

Tags: aerobic exercisecancer rehabilitationchemotherapy-induced peripheral neuropathyevidence mappingexercise interventionsMixed Methods Appraisal Toolmultimodal exerciseneuropathic symptomsneurotoxic agentsplatinum chemotherapyQuality of Liferandomized controlled trialsresistance trainingscoping reviewsupportive care in cancertaxane chemotherapy
Share12Tweet7Share2ShareShareShare1

Related Posts

One Distal Screw Matches Two in Humeral Nailing Functional Outcomes

One Distal Screw Matches Two in Humeral Nailing Functional Outcomes

November 20, 2026
Adipose CD248 Rises in Obesity and Responds Directly to Glucocorticoids

Adipose CD248 Rises in Obesity and Responds Directly to Glucocorticoids

November 20, 2026

Sri Lankan Study Tracks Early Outcomes and Complications Following NICU Discharge

November 20, 2026

Parkinson’s Disease Patients Show Flexible Axial Coordination During Full Circle Turns

November 20, 2026

POPULAR NEWS

  • One Distal Screw Matches Two in Humeral Nailing Functional Outcomes

    One Distal Screw Matches Two in Humeral Nailing Functional Outcomes

    29 shares
    Share 12 Tweet 7
  • Adipose CD248 Rises in Obesity and Responds Directly to Glucocorticoids

    29 shares
    Share 12 Tweet 7
  • Predictable Human Food Prompts Alpine Choughs to Undertake Daily Routine Altitudinal Flights

    29 shares
    Share 12 Tweet 7
  • Alien Plant Spatial Metrics Vary in Reliability Under Simulated Incomplete Sampling

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

One Distal Screw Matches Two in Humeral Nailing Functional Outcomes

Adipose CD248 Rises in Obesity and Responds Directly to Glucocorticoids

Predictable Human Food Prompts Alpine Choughs to Undertake Daily Routine Altitudinal Flights

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 89 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.